52
In band
Moving averages
SMA 200$7.84-65.43%
Company profile
Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacturing, and commercialization of treatments for patients with cancer and other diseases. The company is headquartered in Austin, Texas.
SectorHealthcare
IndustryBiotechnology
Market cap$26.64M
P/E ratio0.179
EPS$21.56
Beta1.419
Dividend yield0.00%
52-week high$23.43
52-week low$2.90
Similar stocks in Biotechnology
BNTX
BioNTech SE
RSI 52
VRTX
Vertex Pharmaceuticals Inc
RSI 64
CRSP
CRISPR Therapeutics AG
RSI 54
IOVA
Iovance Biotherapeutics Inc
RSI 66
RXRX
Recursion Pharmaceuticals Inc - Class A
RSI 51
MRNA
Moderna Inc
RSI 67
VKTX
Viking Therapeutics Inc
RSI 49
SRPT
Sarepta Therapeutics Inc
RSI 67
EDIT
Editas Medicine Inc
RSI 52
NVAX
Novavax Inc
RSI 72
RSI alerts for PSTV
Get an email the moment Plus Therapeutics Inc crosses into oversold or overbought territory. Nothing else, ever.
Add alertData last updated 15 August 2026 at 3:48 AM EDT